X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (104582) 104582
Newspaper Article (23547) 23547
Newsletter (4914) 4914
Book Chapter (1551) 1551
Magazine Article (702) 702
Web Resource (338) 338
Trade Publication Article (289) 289
Book / eBook (120) 120
Dissertation (111) 111
Publication (46) 46
Conference Proceeding (44) 44
Transcript (34) 34
Book Review (25) 25
Government Document (20) 20
Reference (14) 14
Streaming Video (13) 13
Paper (4) 4
Report (3) 3
Journal / eJournal (1) 1
Video Recording (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (82516) 82516
science & technology (63492) 63492
life sciences & biomedicine (60201) 60201
leukemia (54641) 54641
male (37938) 37938
oncology (36608) 36608
female (36570) 36570
hematology (31668) 31668
cancer (24725) 24725
adult (23893) 23893
middle aged (23359) 23359
animals (19211) 19211
aged (17191) 17191
adolescent (15500) 15500
child (14776) 14776
research (14577) 14577
chemotherapy (14530) 14530
mice (13240) 13240
antineoplastic agents - therapeutic use (13130) 13130
antineoplastic combined chemotherapy protocols - therapeutic use (11652) 11652
cancer therapies (11193) 11193
care and treatment (11007) 11007
apoptosis (10684) 10684
leukemia, myeloid, acute - drug therapy (10631) 10631
treatment outcome (9639) 9639
child, preschool (9585) 9585
patients (9027) 9027
prognosis (8916) 8916
clinical trials (8901) 8901
abridged index medicus (8850) 8850
lymphomas (8723) 8723
leukemia - drug therapy (8210) 8210
precursor cell lymphoblastic leukemia-lymphoma - drug therapy (8184) 8184
cell line, tumor (7611) 7611
drug therapy (7458) 7458
antineoplastic agents - pharmacology (7454) 7454
stem cells (7326) 7326
mutation (7210) 7210
tumors (7042) 7042
bone marrow (6908) 6908
proteins (6798) 6798
health aspects (6741) 6741
pediatrics (6692) 6692
leukemia, myelogenous, chronic, bcr-abl positive - drug therapy (6658) 6658
medical research (6629) 6629
remission induction (6377) 6377
apoptosis - drug effects (6349) 6349
acute disease (6235) 6235
chronic myeloid leukemia (6079) 6079
analysis (6042) 6042
kinases (5925) 5925
acute myeloid leukemia (5910) 5910
gene expression (5766) 5766
hemic and lymphatic diseases (5734) 5734
infant (5681) 5681
oncology, experimental (5679) 5679
pharmacology & pharmacy (5652) 5652
pharmaceutical industry (5419) 5419
genetic aspects (5299) 5299
aged, 80 and over (5166) 5166
transplantation (5005) 5005
risk factors (4964) 4964
antineoplastic agents (4924) 4924
medicine (4822) 4822
time factors (4756) 4756
antineoplastic agents - adverse effects (4714) 4714
cell biology (4702) 4702
drug resistance (4630) 4630
immunotherapy (4629) 4629
drug dosages (4553) 4553
immunology (4546) 4546
leukemia, lymphoid - drug therapy (4454) 4454
studies (4397) 4397
leukemia, lymphocytic, chronic, b-cell - drug therapy (4389) 4389
tumor cells, cultured (4372) 4372
imatinib mesylate (4295) 4295
dose-response relationship, drug (4273) 4273
cytarabine - administration & dosage (4268) 4268
young adult (4258) 4258
retrospective studies (4215) 4215
antimitotic agents (4143) 4143
recurrence (4095) 4095
leukemia, myeloid - drug therapy (4004) 4004
biochemistry & molecular biology (3966) 3966
medical prognosis (3938) 3938
acute lymphocytic leukemia (3934) 3934
cell cycle (3925) 3925
chronic lymphocytic leukemia (3919) 3919
medicine & public health (3919) 3919
fda approval (3799) 3799
research article (3755) 3755
flow cytometry (3753) 3753
antineoplastic combined chemotherapy protocols - adverse effects (3701) 3701
follow-up studies (3616) 3616
pyrimidines - therapeutic use (3595) 3595
antineoplastic agents - administration & dosage (3574) 3574
leukemia, myeloid, acute - pathology (3536) 3536
hematology, oncology and palliative medicine (3518) 3518
signal transduction (3515) 3515
leukemia, myeloid, acute - genetics (3512) 3512
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (70) 70
Online Resources - Online (21) 21
Collection Dvlpm't (Acquisitions) - Vendor file (14) 14
Collection Dvlpm't (Acquisitions) - Closed Orders (7) 7
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (5) 5
St. Michael's College (John M. Kelly) - 2nd Floor (2) 2
UofT at Mississauga - Stacks (2) 2
Baycrest Hospital - Wellness Library (1) 1
Credit Valley Hospital - Stacks (1) 1
Gerstein Science - Circulation Desk (1) 1
Media Commons - Audio Visual (1) 1
New College (Ivey) - Stacks (1) 1
St. Michael's Hospital - Stacks (1) 1
Sunnybrook Health Sciences Centre - Sunnybrook Reference (1) 1
Thomas Fisher Rare Book - Rare Book (1) 1
UTL at Downsview - May be requested (1) 1
University College (Laidlaw) - Stacks (1) 1
UofT Schools - Stacks (1) 1
UofT at Scarborough - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (128507) 128507
Japanese (2604) 2604
German (1717) 1717
French (1245) 1245
Chinese (1122) 1122
Russian (1091) 1091
Spanish (662) 662
Italian (538) 538
Polish (521) 521
Portuguese (169) 169
Czech (122) 122
Hungarian (113) 113
Norwegian (90) 90
Dutch (88) 88
Danish (81) 81
Swedish (59) 59
Hebrew (43) 43
Croatian (42) 42
Serbian (41) 41
Romanian (34) 34
Turkish (30) 30
Korean (24) 24
Slovak (24) 24
Finnish (23) 23
Ukrainian (12) 12
Bulgarian (9) 9
Arabic (5) 5
Persian (5) 5
Urdu (4) 4
Afrikaans (3) 3
Slovenian (3) 3
Bosnian (2) 2
Catalan (1) 1
Galician (1) 1
Hindi (1) 1
Nauru (1) 1
Thai (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Leukemia, ISSN 0887-6924, 07/2011, Volume 25, Issue 7, pp. 1064 - 1079
... (mTOR) pathway is often implicated in sensitivity and resistance to therapy. Dysregulated signaling through the PI3K/PTEN/Akt/mTOR pathway is often the result... 
mTOR | translation | sensitivity | PI3K | therapy | resistance | Oncology | Life Sciences & Biomedicine | Hematology | Science & Technology | Apoptosis - drug effects | Neoplastic Stem Cells - drug effects | Humans | Neoplasm Proteins - physiology | PTEN Phosphohydrolase - physiology | Apoptosis - genetics | Neoplasm Proteins - antagonists & inhibitors | Antineoplastic Agents - therapeutic use | Molecular Targeted Therapy | Phosphatidylinositol 3-Kinases - antagonists & inhibitors | Proto-Oncogene Proteins c-akt - genetics | Gene Expression Regulation, Leukemic - genetics | Mechanistic Target of Rapamycin Complex 1 | Multiprotein Complexes - antagonists & inhibitors | Transcription Factors - drug effects | TOR Serine-Threonine Kinases - antagonists & inhibitors | PTEN Phosphohydrolase - antagonists & inhibitors | TOR Serine-Threonine Kinases - genetics | Protein Processing, Post-Translational - drug effects | Drug Design | TOR Serine-Threonine Kinases - physiology | Antineoplastic Agents - pharmacology | Phosphorylation - drug effects | Neoplasm Proteins - genetics | Leukemia - genetics | Multiprotein Complexes - drug effects | PTEN Phosphohydrolase - genetics | Proteins - physiology | Transcription Factors - physiology | RNA, Messenger - genetics | Gene Expression Regulation, Leukemic - drug effects | Leukemia - drug therapy | Transcription Factors - antagonists & inhibitors | Proto-Oncogene Proteins c-akt - physiology | Multiprotein Complexes - physiology | Phosphatidylinositol 3-Kinases - genetics | Drug Resistance, Neoplasm - genetics | Pseudogenes | Signal Transduction - drug effects | Phosphatidylinositol 3-Kinases - physiology | Proteins - drug effects | RNA, Neoplasm - genetics | Protein Biosynthesis - drug effects | MicroRNAs - genetics | Proteins - antagonists & inhibitors | Proto-Oncogene Proteins c-akt - antagonists & inhibitors | Drug Resistance, Neoplasm - drug effects | Antimitotic agents | Genes | Leukemia | Physiological aspects | Development and progression | Genetic aspects | Research | Antineoplastic agents | Drug therapy | Health aspects | Index Medicus
Journal Article
2008, ISBN 9780199225859, xvii, 516
Highly active antiretroviral therapy (HAART) is a therapeutic intervention developed by clinicians and researchers in order to fight the HIV pandemic... 
Highly active antiretroviral therapy | HIV infections | Chemotherapy | History | AIDS (Disease) | Epidemiology | Public Health | HIV treatment | AIDS | HIV | HAART
Book
Leukemia, ISSN 1476-5551, 04/2011, Volume 25, Issue 7, pp. 1080 - 1094
...) pathway is often implicated in sensitivity and resistance to leukemia therapy. Dysregulated signaling through the Ras/Raf/MEK/ERK pathway is often the result... 
targeted therapy | Ras | therapeutic sensitivity | Raf | resistance | ERK | Oncology | Life Sciences & Biomedicine | Hematology | Science & Technology | ras Proteins - genetics | MAP Kinase Signaling System - physiology | Mitogen-Activated Protein Kinase Kinases - genetics | Apoptosis - drug effects | raf Kinases - antagonists & inhibitors | Humans | Neoplasm Proteins - physiology | Mitogen-Activated Protein Kinase Kinases - physiology | Extracellular Signal-Regulated MAP Kinases - antagonists & inhibitors | Neoplasm Proteins - antagonists & inhibitors | Antineoplastic Agents - therapeutic use | Molecular Targeted Therapy | Phosphatidylinositol 3-Kinases - antagonists & inhibitors | Extracellular Signal-Regulated MAP Kinases - genetics | Gene Expression Regulation, Leukemic - genetics | raf Kinases - physiology | MAP Kinase Signaling System - genetics | Drug Design | Antineoplastic Agents - pharmacology | Extracellular Signal-Regulated MAP Kinases - physiology | Neoplasm Proteins - genetics | raf Kinases - genetics | ras Proteins - physiology | Cell Division - genetics | Mitogen-Activated Protein Kinase Kinases - antagonists & inhibitors | ras Proteins - antagonists & inhibitors | Gene Expression Regulation, Leukemic - drug effects | Leukemia - drug therapy | Cell Division - drug effects | Phosphatidylinositol 3-Kinases - genetics | Drug Resistance, Neoplasm - genetics | MAP Kinase Signaling System - drug effects | Models, Biological | Phosphatidylinositol 3-Kinases - physiology | Apoptosis - physiology | Drug Resistance, Neoplasm - physiology | Drug Resistance, Neoplasm - drug effects | Chemotherapy | Extracellular signal-regulated kinases | Leukemia | Physiological aspects | Genetic aspects | Research | Drug therapy | Health aspects | Mitogen-activated protein kinases | Cancer | Index Medicus
Journal Article
PloS one, ISSN 1932-6203, 11/2016, Volume 11, Issue 11, pp. e0165737 - e0165737
Journal Article